ALMS ALUMIS INC.

ALMS financial statements, revenue, balance sheet, cash flow, and SEC filings

CIK: 1847367 Exchange: Nasdaq SIC: 2834 (Pharmaceutical Preparations) Latest filing: 10-Q filed Aug 13, 2026 Data checked: Oct 21, 2026
Showing 3 of 3 annual and 0 of 12 quarterly periods. Full history available with a free account or via API.

▼ Company Profile

Filer Category
<br>Emerging growth company
Entity Type
Operating
Public Float
$183.20M (Jun 2025)
Industry (SIC)
2834 Pharmaceutical Preparations
Incorporated
DE
Fiscal Year End
December (1231)
Phone
650-231-6625
EIN
000000000
Headquarters
SOUTH SAN FRANCISCO, CA, 94080
Public Float History
Market value of shares held by public investors, reported in annual DEI filings.
Former Names: FL2021-001, Inc. (2021–2021)

▼ Key Metrics (TTM)

As of Jun 30, 2026
Financials
Revenue
$7.40M
Net Income
$-438.96M
Total Assets
$560.62M
Total Equity
$452.16M
Total Debt
-
Free Cash Flow
$-351.80M
Ratios
Operating Margin
-6204.4%
Net Margin
-5933.5%
Return on Equity
-97.1%
Return on Assets
-78.3%
Current Ratio
6.74x
FCF / Assets
-62.8%

▼ FY 2025 Summary Analysis

Annual report ending Dec 31, 2025

Overview and Growth

Fiscal 2025 results for ALUMIS INC. combined $24.05M of revenue with net loss of $243.32M and an operating cash outflow of $369.52M. Revenue of $24.05M sets the scale for evaluating how effectively sales translated into profit and cash during the year. Diluted earnings per share were -$2.86, translating the period’s attributable earnings into the amount reported for each diluted share. A diluted share base of 85.03M links the aggregate earnings figure to diluted EPS and helps frame the per-share comparison. Diluted shares moved 200.0% from 28.34M in fiscal 2024, leaving the current share base higher year over year. The company employed $411.94M of total assets, the balance-sheet base supporting its current operating and cash-flow results. Asset turnover was 0.06x, relating the company’s annual revenue directly to the total assets reported at the period end.

Profitability

The reported operating result was an operating loss of $453.80M, reflecting costs that exceeded gross profit. After all below-operating-line items, the company recorded a net loss of $243.32M for the fiscal year. The company reported negative EBITDA of $450.30M, adding a pre-interest, tax, depreciation, and amortization view of the operating shortfall. The company reported a pretax loss of $251.89M, before the effect of income taxes. The company recognized an income-tax benefit of $8.56M, increasing after-tax earnings relative to the pretax result. Relative to period-end equity, the net loss represented 80.8%. The net loss equaled 59.1% of period-end assets, showing the deficit relative to the asset base. Compared with a $294.23M net loss in fiscal 2024, the current loss improved to $243.32M.

Liquidity and Capital Structure

Total assets were $411.94M, supported by $110.64M of liabilities and $301.30M of shareholder equity. At period end, current assets of $318.23M compared with current liabilities of $73.32M, defining the company’s short-term resource position. The current ratio was 4.34x, with current assets exceeding current liabilities and providing a short-term liquidity cushion. Reported cash and equivalents were $89.67M, separating immediately recognizable cash resources from the rest of the current-asset base. The cash balance equaled 122.3% of current liabilities, showing how much near-term coverage came from cash alone. Equity equaled 73.1% of assets, showing the shareholder-capital layer within the company’s balance sheet. The liabilities-to-assets relationship was 26.9%, placing reported obligations against the full positive asset balance. Measured against total assets, cash and equivalents represented 21.8%, a balance-sheet composition measure rather than a liquidity forecast. Total assets were 20.8% higher than fiscal 2024 assets of $340.99M, measuring the company’s own balance-sheet change. Book equity was 15.8% higher than fiscal 2024 equity of $260.10M, showing how shareholder capital changed year over year. Cash and equivalents were 47.1% lower than fiscal 2024 cash of $169.53M, showing the year-over-year change in liquid resources.

Cash Flow and Earnings Quality

Operating activities used $369.52M of cash, resulting in an operating cash outflow for the year. Capital spending of $653.00K added to the period’s operating cash use, reinforcing the overall cash deficit after investment for the year. The company recorded a $370.18M cash deficit after capital spending for the period. The free-cash-flow deficit equaled 89.9% of total assets, placing the cash shortfall against the company’s resource base. The operating cash outflow widened to $369.52M from $255.08M in fiscal 2024.
Based on the annual report for the fiscal year ending Dec 31, 2025. Analysis generated .
Sources and calculation details

Reported values are preserved. Derived values use the listed inputs; unavailable inputs remain blank.

Field-level sources for this historical record are unavailable until it is rebuilt from SEC facts.

Annual financial statements for ALUMIS INC.
Metric FY2025 📄 FY2024 📄 FY2023 📄
Income Statement
REVENUE
Revenue $24.05M - -
OPERATING EXPENSES
R&D Expense $386.00M $265.55M $137.68M
SG&A Expense $91.86M $35.20M $20.50M
Operating Income $-453.80M $-300.75M $-158.17M
NON-OPERATING INCOME / EXPENSE
Other Income/Expense $-169.00K $-93.00K $-68.00K
Pretax Income $-251.89M $-294.23M -
Income Tax $-8.56M $0 $0
Net Income $-243.33M $-294.23M $-154.99M
PER SHARE & SUPPLEMENTAL
Diluted EPS $-2.86 $-10.38 $-72.08
Diluted Shares 85.03M 28.34M 2.15M
EBITDA $-450.30M $-297.55M $-156.87M
Depreciation & Amortization $3.50M $3.20M $1.30M
Balance Sheet
ASSETS
Cash & Equivalents $89.67M $169.53M $46.00M
Short-term Investments $218.83M $118.74M $2.96M
Other Current Assets $6.74M $4.50M $1.63M
Current Assets $318.23M $306.19M $53.36M
PP&E (Net) $18.19M $20.97M $22.44M
Other Noncurrent Assets $6.29M $7.00K $7.00K
Noncurrent Assets $93.71M $34.80M $36.26M
Total Assets $411.94M $340.99M $89.61M
LIABILITIES
Accounts Payable $10.11M $9.62M $1.12M
Other Current Liabilities $81.00K $158.00K $409.00K
Current Liabilities $73.32M $50.91M $20.87M
Other Noncurrent Liabilities $207.00K - -
Noncurrent Liabilities $37.33M $29.98M $32.63M
Total Liabilities $110.64M $80.89M $53.50M
EQUITY
Additional Paid-in Capital $1.20B $918.61M $25.06M
Retained Earnings $-901.88M $-658.55M $-364.32M
Accumulated OCI $188.00K $40.00K $2.00K
Total Equity $301.30M $260.10M $-339.26M
Temporary Equity - - $375.37M
Total Liabilities & Equity $411.94M $340.99M $89.61M
SUPPLEMENTAL
Check: A − (L + E + Temp. Equity) - - -
Cash Flow Statement
Cash from Operations $-369.52M $-255.08M $-129.98M
Capital Expenditures $653.00K $1.73M $4.50M
Cash from Investing $287.88M $-113.79M $60.47M
Cash from Financing $2.07M $492.37M $89.68M
Free Cash Flow $-370.18M $-256.81M $-134.47M
Beginning Cash (CFS) $170.63M $47.13M $26.95M
Net Change in Cash $-79.58M $123.50M $20.18M
Effect of FX on Cash - - -
Calculated Ending Cash $91.05M $170.63M $47.13M
Cash per BS $89.67M $169.53M $46.00M
Cash scope difference (CFS − BS) $1.38M $1.11M $1.14M
Cash per CFS $91.05M $170.63M $47.13M

Create a free account to see full history, quarterly data, charts, CSV downloads, and API access.

Create Free Account Log In
🔒

Quarterly data and charts require a free account

Get access to 8 quarters of data, interactive charts, CSV downloads, and API access.

▼ Frequently Asked Questions

What is ALUMIS INC.'s annual revenue?

ALUMIS INC. reported $7.40M in revenue for trailing twelve months (ending June 2026). Revenue figures are sourced from the company's annual SEC EDGAR filing.

Is ALUMIS INC. profitable?

No. ALUMIS INC. reported $-438.96M in net income for trailing twelve months. Profitability data is based on the company's most recent annual report filed with the SEC.

Does ALUMIS INC. generate free cash flow?

No. Free cash flow was $-351.80M for trailing twelve months. Operating cash flow was $-351.40M.